You are not logged in.

Primary systemic therapy in HER2-amplified breast cancer : a clinical review

Khasraw, Mustafa and Bell, Richard 2012, Primary systemic therapy in HER2-amplified breast cancer : a clinical review, Expert review of anticancer therapy, vol. 12, no. 8, pp. 1005-1013, doi: 10.1586/era.12.62.

Attached Files
Name Description MIMEType Size Downloads

Title Primary systemic therapy in HER2-amplified breast cancer : a clinical review
Author(s) Khasraw, MustafaORCID iD for Khasraw, Mustafa orcid.org/0000-0003-3249-9849
Bell, Richard
Journal name Expert review of anticancer therapy
Volume number 12
Issue number 8
Start page 1005
End page 1013
Total pages 9
Publisher Expert Reviews
Place of publication London, England
Publication date 2012
ISSN 1473-7140
1744-8328
Keyword(s) HER2-positive breat cancer
neoadjuvant chemotherapy
primary systemic therapy
trastuzumab
Summary Primary systemic therapy (PST) in early breast cancer is utilized in locally advanced breast tumors and when breast-conserving surgery is desirable. In addition, the PST setting provides an opportunity to monitor response including histopathological and biomarker examination of the tumor and host tissues before and after systemic therapy. Trastuzumab is a monoclonal antibody targeting the hEGF receptor that is overexpressed in 15–20% of breast tumors. Trastuzumab is effective in prolonging survival when used to treat women with hEGF receptor overexpressed tumors, both in adjuvant and metastatic disease settings. Trastuzumab has also shown promising activity in PST/neoadjuvant studies by achieving high rates of complete pathologic response. This is a review of clinical studies that incorporated trastuzumab in PST and/or neoadjuvant chemotherapy, including the results of recently reported studies using trastuzumab in combination with other novel therapies such as lapatinib or pertuzumab.
Language eng
DOI 10.1586/era.12.62
Field of Research 119999 Medical and Health Sciences not elsewhere classified
Socio Economic Objective 970111 Expanding Knowledge in the Medical and Health Sciences
HERDC Research category C1 Refereed article in a scholarly journal
Copyright notice ©2012, Expert Reviews
Persistent URL http://hdl.handle.net/10536/DRO/DU:30048957

Document type: Journal Article
Collection: School of Medicine
Connect to link resolver
 
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.

Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 7 times in TR Web of Science
Scopus Citation Count Cited 9 times in Scopus
Google Scholar Search Google Scholar
Access Statistics: 206 Abstract Views, 0 File Downloads  -  Detailed Statistics
Created: Thu, 11 Oct 2012, 10:46:25 EST by Leanne Swaneveld

Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.